“Generic drugs are supposed to be a more affordable alternative, and through this litigation and settlement, we are holding the companies that have kept prices artificially high accountable for taking advantage of families. We are committed to taking action to lower your drug costs and we will continue to pursue transparency, accountability, and affordability for Mississippi consumers,” said Attorney General Lynn Fitch. The States have also secured settlements in the same litigation with Glenmark, Lannett, Bausch, Apotex and Heritage totaling approximately $96.5 million. If approved, Sandoz Inc. will pay a total of approximately $469 million to settle the claims brought by the states, including amounts paid pursuant to previous settlements with other states. This settlement is contingent upon obtaining signatures from all necessary states and territories and comes as the States prepare for an anticipated trial in 2027.